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Abstract Addition of, or gulonolactone oxidase-dependent in
situ generation of, ascorbate provoked the oxidation of protein
thiols, which was accompanied by ascorbate consumption in liver
microsomal vesicles. The maximal rate of protein thiol oxidation
was similar upon gulonolactone, ascorbate or dehydroascorbate
addition. Cytochrome P450 inhibitors (econazole, proadifen,
quercetin) decreased ascorbate consumption and the gulonolac-
tone or ascorbate-stimulated thiol oxidation. The results
demonstrate that the ascorbate/dehydroascorbate redox couple
plays an important role in electron transfer from protein thiols to
oxygen in the hepatic endoplasmic reticulum, even in gulono-
lactone oxidase deficient species.
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1. Introduction
The endoplasmic reticulum (ER) of the cell is the site of
synthesis, post-translational modi¢cation and folding of pro-
teins transported along the secretory pathway. The oxidizing
environment in the lumen of the ER is necessary for the for-
mation of disul¢de bonds and for the proper folding of these
proteins (for recent comprehensive reviews on the topic, see
[1,2]). The formation of native disul¢de bonds is catalyzed by
protein disul¢de isomerase [3]. The e¡ect of unknown oxi-
dant(s), necessary for its activity, is re£ected in and supported
by the glutathione redox bu¡er. The ratio of glutathione
(GSH) and glutathione disul¢de (GSSG) is around 2:1 within
the lumen of ER and along the secretory pathway, whilst the
cytosolic ratio ranges from 30:1 to 100:1 [4]. However, the
primary source(s) and the mechanism of the oxidative envi-
ronment remain to be elucidated. Recent observations suggest
two possible mechanisms. First, the preferential uptake of the
oxidized member of a redox couple through the ER mem-
brane and/or the e¥ux (or exocytosis) of its reduced form
could ensure the oxidative environment. Alternatively, en-
zymes resident in the membrane or lumen of the ER could
produce oxidizing compounds (e.g. reactive oxygen species)
towards the lumen. Experimental evidences support both
mechanisms. On the one hand, the preferential transport of
dehydroascorbate (the oxidized form of ascorbate) has been
described in rat liver microsomal vesicles [5]. In contrast,
GSSG transport seems to be negligible [6]. On the other
hand, several microsomal enzymes (cytochrome P450s,
NADPH cytochrome P450 reductase, gulonolactone oxidase,
microsomal iron protein, NADPH-dependent oxidase, sulf-
hydryl oxidase, £avin-containing monooxygenase etc.) can
produce reactive oxygen species [7^14]. The recent exploration
of yeast ER oxidase protein (Ero1p) and its role in the protein
folding supports also the latter mechanism [15,16]. However,
little direct information is available on the enzymatic mecha-
nism and redox partners of Ero1p. There are no data about
either the source of the oxidizing equivalents or the target to
which it transfers them. It can oxidize an intermediate carrier
(e.g. GSH) or directly the reduced proteins.
The role of ascorbate in the electron transfer from proteins
has been suggested for a long time [17]. Topological coinci-
dences support this view in case of disul¢de bond formation:
the last steps of ascorbate synthesis are located in the ER [18].
Gulonolactone oxidase, an ER resident £avoenzyme catalyz-
ing the ¢nal reaction of ascorbate biosynthesis, is known to
produce the oxidant hydrogen peroxide as a byproduct [18].
Ascorbate itself can also behave as a pro-oxidant under some
circumstances [19]. It has been observed that gulonolactone
oxidase activity stimulated by gulonolactone addition results
in the oxidation of GSH both in isolated hepatocytes and in
the microsomal system [20]. In GSH-loaded microsomal
vesicles, the reaction led to intraluminal GSSG formation
[7]. Since recent observations indicate that GSH can compete
with protein thiols for the oxidizing agent [21], it can be sup-
posed that the oxidizing agent generated by gulonolactone
oxidase activity contributes to the disul¢de bridge formation
in proteins. In the present work, therefore, the e¡ect of ascor-
bate and its metabolism on the oxidation of protein thiols of
the ER has been investigated.
2. Materials and methods
2.1. Materials
L-Gulono-Q-lactone, 5,5P-dithio-bis(2-nitrobenzoic acid), econazole,
proadifen, quercetin, alamethicin, K,KP-dipyridyl and ascorbate were
obtained from Sigma. Dehydroascorbate was prepared as described
earlier [5]. All other chemicals were of analytical grade.
2.2. Preparation of liver microsomes
Microsomes were prepared from male Wistar rats (180^230 g) or
male guinea pigs (700^750 g) as described in [22]. Animals were ob-
tained from Charles River (Budapest, Hungary). Human liver micro-
somes were prepared from the marginal normal tissues of liver tumors
removed by surgical operation. The Ethical Committee of the Uni-
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versity approved the use of human samples. Microsomal fractions
were resuspended in a bu¡er containing 100 mM KCl, 20 mM
NaCl, 1 mM MgCl2, 20 mM morpholinepropanesulfonic acid
(Mops), pH 7.2. The suspensions were rapidly frozen and maintained
under liquid N2 until required. The intactness of microsomal mem-
brane was checked by the measurement of the latencies of mannose-6-
phosphatase [23] and p-nitrophenol UDP-glucuronosyltransferase [24]
activities, which were greater than 90 and 95%, respectively.
2.3. Incubation of microsomes and the measurement of metabolites
For the determination of protein thiol oxidation and ascorbate syn-
thesis/consumption, intact or permeabilized microsomal vesicles (usu-
ally 1 mg protein/ml) were incubated in a bu¡er containing 100 mM
KCl, 20 mM NaCl, 1 mM MgCl2, 20 mM Mops, pH 7.2, at 37‡C. For
permeabilization, microsomes were treated with alamethicin (0.05 mg/
mg protein) [24]. Incubations were terminated by the addition of 0.05
volume of 100% trichloroacetic acid. Ascorbate contents were meas-
ured in trichloroacetic acid soluble supernatants by the method of
Omaye et al. [25], based on the reduction of Fe3 with the oxidation
of ascorbate and the subsequent determination of the Fe2-K,KP-di-
pyridyl complex. Protein thiols were measured in the washed and
resuspended pellets by the Ellman method [26]. Microsomal ascorbate
and dehydroascorbate formation upon gulonolactone addition was
also measured by reverse phase high-pressure liquid chromatography
(HPLC) after a speci¢c sample preparation as described earlier [27].
The protein concentration of microsomes was determined by using
Bio-Rad protein assay solution with bovine serum albumin as stand-
ard according to the manufacturer’s instructions. All data were ex-
pressed as means þ S.D.
3. Results
3.1. Ascorbate-dependent oxidation of protein thiols in liver
microsomes
Rat, guinea pig or human liver microsomal vesicles were
incubated in the presence of a cytosol-like concentration of
ascorbate (0.1 mM). The disappearance of protein thiols and
the consumption of ascorbate were measured. In the absence
of ascorbate, the amount of protein thiols was unchanged up
to 1 h incubation. Ascorbate addition resulted in a decrease of
the protein thiol concentration (Table 1), which was due to
their oxidation, since they could be reduced back with mer-
captoethanol (data not shown). In rat liver microsomes, 1 h
incubation resulted in the oxidation of about 50% of protein
thiols (19.9 þ 2.4 nmol/mg protein, mean þ S.D., n = 7), which
increased to 70% (28.8 þ 5.1 nmol/mg protein, mean þ S.D.,
n = 6) after 2 h. No signi¢cant further oxidation could be
observed at later times, although ascorbate was still present
in the medium. The thiol oxidation was accompanied by as-
corbate consumption, which suggested that ascorbate was oxi-
dized in the process, so the e¡ect of dehydroascorbate was
also investigated. It caused thiol oxidation while it was re-
duced to ascorbate but it was less e¡ective than ascorbate
even at a concentration of 1 mM (Table 1). Acceleration of
ascorbate oxidation by hydrogen peroxide increased ascorbate
consumption but the oxidation of protein thiols did not in-
crease proportionally (Table 1). In control experiments, hy-
drogen peroxide in a 1 mM concentration was almost ine¡ec-
tive (Table 1). Even at 10 mM, it caused only a negligible
decrease in protein thiols in the absence of added ascorbate
(data not shown).
3.2. Gulonolactone oxidase activity-dependent oxidation of
microsomal protein thiols
Gulonolactone, the substrate of gulonolactone oxidase, was
added to rat microsomal vesicles to study the putative role of
in situ ascorbate synthesis in microsomal protein thiol oxida-
tion. Ascorbate synthesis from gulonolactone resulted in the
oxidation of protein thiols (Table 2). The apparent Michaelis
constant for the reaction was 8.1 WM and the apparent max-
imal rate was 315 pmol/min/mg protein (Fig. 1a). The time
course of the reaction measured in the presence of 1 mM
gulonolactone showed that after an initial lag phase (W15
min), the rate of protein thiol disappearance was linear up
to 1 h (Fig. 1b). The oxidizing e¡ect was due to the metabo-
lism of gulonolactone. The e¡ect was totally absent in human
or guinea pig liver microsomes, which do not have gulonolac-
tone oxidase activity (Fig. 1b). Ascorbate generated by gulo-
nolactone oxidase was further oxidized and dehydroascorbate
formation could be observed (Fig. 2).
3.3. Inhibition of ascorbate-mediated microsomal protein thiol
oxidation by cytochrome P450 inhibitors
The enzymatic nature of electron transfer was investigated
by using inhibitors of the possible enzymes involved. It has
Table 1
E¡ect of ascorbate (AA) on the oxidation of protein thiols in rat, guinea pig and human liver microsomal vesicles
Addition Rat liver microsomes Guinea pig liver microsomes Human liver microsomes
Oxidation of
protein thiols
Ascorbate
consumption
Oxidation of
protein thiols
Ascorbate
consumption
Oxidation of
protein thiols
Ascorbate
consumption
pmol/min/mg protein
None 12 þ 34 (8) 30 þ 14 (8) 18 þ 23 (3) ND 2 þ 2 (4) ND
1 mM H2O2 26 þ 43 (6) NM 52 þ 5 (3) ND 7 þ 16 (3) ND
0.1 mM AA 332 þ 40 (7) 362 þ 68 (8) 135 þ 81 (4) 149 þ 59 (4) 149 þ 35 (7) 407 þ 128 (7)
0.1 mM AA+1 mM H2O2 448 þ 46 (4) 808 þ 161 (4) NM NM 174 þ 28 (3) 610 þ 84 (3)
0.1 mM AA+10 mM H2O2 325 þ 15 (5) 762 þ 63 (3) 164 þ 34 (3) 1 653 þ 137 (3) 217 þ 49 (4) 1 541 þ 271 (4)
1 mM dehydroascorbate 259 þ 10 (5) 3410 þ 163 (5) 82 þ 4 (3) 3295 þ 34 (3) 101 þ 26 (3) 3294 þ 55 (3)
0.1 mM AA+0.1 mM
econazole
181 þ 19 (6) 131 þ 8 (6) 31 þ 31 (3) 9 þ 13 (3) 86 þ 5 (3) 93 þ 70 (3)
0.1 mM AA+0.1 mM
proadifen
62 þ 5 (3) 6 þ 11 (3) NM NM NM NM
0.1 mM AA+0.1 mM
quercetin
119 þ 28 (3) 137 þ 17 (3) NM NM NM NM
0.1 mM AA+10 mM
H2O2+0.1 mM econazole
69 þ 33 (3) 301 þ 16 (3) 92 þ 3 (3) 733 þ 102 (3) 172 þ 4 (4) 933 þ 331 (4)
Microsomes (1 mg protein/ml) were incubated in the presence of the indicated compounds for 60 min at 37‡C. The change in the amount of
protein thiols and ascorbate was measured. The initial protein thiol contents were 40.2 þ 1.8 nmol/mg protein (mean þ S.D., n = 16), 52.2 þ 4.4
(6) and 42.3 þ 2.8 (8) nmol/mg protein, respectively. Data are means þ S.D. (n). AA, ascorbate; ND, not detectable; NM, not measured.
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been found that various cytochrome P450 inhibitors (econa-
zole, proadifen, quercetin) decreased both ascorbate consump-
tion and protein thiol oxidation in rat liver microsomes (Table
1). Econazole e¡ectively diminished the oxidation of protein
thiols and ascorbate consumption also in (ascorbate or ascor-
bate plus hydrogen peroxide-treated) guinea pig and human
microsomes (Table 1).
Econazole inhibited the gulonolactone oxidase-dependent
thiol oxidation without decreasing the rate of ascorbate syn-
thesis in rat liver microsomes. Moreover, it seems to make
ascorbate synthesis more active, probably due to the lower
ascorbate consumption (Table 2).
4. Discussion
In intact hepatocytes, the protein thiols of newly synthe-
sized secretory proteins continuously undergo an oxidation
in the lumen of the ER. The fact that protein disul¢de bridge
formation does not proceed in ER-derived liver microsomal
vesicles suggests that the process needs a cytosolic factor or a
membrane-permeable compound that is lost during the prep-
aration of microsomes. GSSG has long been thought to act as
an electron acceptor in the process. However, recent observa-
tions seem to exclude this possibility: protein disul¢de forma-
tion is normal in GSH de¢cient yeast [15], GSH can even
Table 2
E¡ect of gulonolactone oxidase activity on the oxidation of protein thiols in rat liver microsomal vesicles
Addition Oxidation of protein thiols Ascorbate production
pmol/min/mg protein (n)
None 12 þ 34 (8) 330 þ 14 (8)
1 mM gulonolactone 249 þ 18 (8) 1 854 þ 153 (8)
0.1 mM econazole 315 þ 18 (5) 127 þ 85 (4)
1 mM gulonolactone+0.1 mM econazole 50 þ 22 (5) 2 014 þ 27 (5)
Microsomes (1 mg protein/ml) were incubated in the presence of the indicated compounds for 60 min at 37‡C. The change in the amount of
protein thiols and ascorbate was measured. The initial protein thiol content was 40.2 þ 1.8 nmol/mg protein (mean þ S.D., n = 16). Data are
means þ S.D. (n).
Fig. 1. Gulonolactone concentration and time-dependence of protein thiol oxidation in rat liver microsomal vesicles. Microsomes (1 mg pro-
tein/ml) were incubated in the presence of various concentrations of gulonolactone for 60 min (a) or in the presence of 1 mM gulonolactone
for the indicated times (b, circles) at 37‡C. The disappearance of protein thiols was measured. The initial protein thiol content of microsomes
was 40.2 þ 1.8 nmol/mg protein (mean þ S.D., n = 16). For comparison, the absence of gulonolactone e¡ect in guinea pig liver microsomes is
also shown (b, triangles). Data are means of 8^16 experiments, S.D. values were less than 10% of means.
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compete with protein thiols for oxidizing agents [21] and
GSSG is hardly transported through the ER membrane [6].
The present paper demonstrates that ascorbate may play a
crucial role in this electron transfer chain.
Ascorbate can derive from two sources in the lumen of the
hepatic ER. Exogenous ascorbate (or its oxidized form, dehy-
droascorbate) enters from the cytosol in ascorbate non-syn-
thesizing species (e.g. guinea pig and human). Both com-
pounds are transported through the ER membrane [5]. In
animals that express a functioning gulonolactone oxidase
(e.g. rat), ascorbate is de novo synthesized directly in the lu-
men of the ER [7]. In both cases, ascorbate must be oxidized
to become an electron acceptor. It might be the function of a
microsomal ascorbate oxidase activity, which has already been
reported [28]. Accordingly, oxidation of the added or in situ
produced ascorbate was found in our experimental systems.
Gulonolactone addition also gave rise to dehydroascorbate,
the ultimate product of ascorbate oxidation.
Ascorbate addition provoked protein thiol oxidation in the
liver microsomes of all the studied species. Dehydroascorbate,
in agreement with previous ¢ndings [29,30], also oxidizes pro-
tein thiols with a simultaneous ascorbate formation. The max-
imal rate of protein thiol oxidation was similar in the case of
gulonolactone, ascorbate, ascorbate plus hydrogen peroxide
or dehydroascorbate addition, suggesting that the rate limit-
ing step in the electron transfer is between protein thiols and
ascorbate, e.g. the activity of protein disul¢de isomerase.
It is also demonstrated that gulonolactone oxidase activity
results in the oxidation of protein thiols in the hepatic ER of
ascorbate-synthesizing species. Although the concentration of
gulonolactone in hepatocytes is not known, the very low vir-
tual KM of the gulonolactone-provoked thiol oxidation
strongly suggests the physiological relevance of the process.
The oxidizing e¡ect could logically be attributed to hydrogen
peroxide, an oxidant produced by gulonolactone oxidase.
However, the addition of hydrogen peroxide even in a high
concentration (10 mM, which is about two orders of magni-
tude higher than the one produced from gulonolactone oxi-
dation in the microsomal vesicles during 1 h incubation) can-
not mimic the e¡ect. This observation indicates that the other
product of the enzyme, ascorbate, must play a role.
We have found that three typical cytochrome P450 inhib-
itors of various structures (econazole, proadifen and quercetin
[31^33]) inhibit the electron £ow from protein thiols to oxy-
gen. In their presence, protein thiols and ascorbate remained
in the reduced form. In other words, they decreased ascorbate
oxidation and consequently gulonolactone, ascorbate or as-
corbate plus hydrogen peroxide-dependent thiol oxidation,
but did not a¡ect gulonolactone oxidase activity. It suggests
that the electron transfer from ascorbate to oxygen (and/or
hydrogen peroxide) is an enzymatic process possibly mediated
by a cytochrome P450 isozyme. Ascorbate as an electron do-
nor in cytochrome P450-catalyzed drug oxidation has already
been reported [34].
The overall process with some modi¢cations supports the
model for the proposed role of dehydroascorbate in the pro-
tein disul¢de isomerase-catalyzed formation of protein disul-
¢des [35]. Ascorbate oxidase and peroxidase activities present
in the microsomal vesicles oxidize ascorbate to dehydroascor-
bate. Dehydroascorbate (formed in or transported into the
lumen of the ER) can be reduced by protein disul¢de isomer-
ase [36], oxidizing the active center dithiols of the enzyme.
Oxidized protein disul¢de isomerase reacts with reduced nas-
cent proteins, yielding protein disul¢des and catalytically re-
generating protein disul¢de isomerase.
The participation of small molecular weight compounds
(quinones) has been reported in the electron transfer chain
of prokaryotic protein disul¢de formation [37]. In the present
paper, a similar role of ascorbate is shown in the mammalian
ER. The oxidation of protein thiols in the presence of very
low concentrations of gulonolactone or cytosolic-like concen-
trations of ascorbate strongly suggests the physiological rele-
vance of these e¡ects.
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